State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing, 210009, PR China.
State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing, 210009, PR China.
Biomaterials. 2019 Dec;225:119515. doi: 10.1016/j.biomaterials.2019.119515. Epub 2019 Sep 27.
Tumor-associated macrophages (TAMs) are abundant in many cancers, and predominately display an immunosuppressive M2-like function that fosters tumor progression and promotes malignant metastasis. Current TAMs repolarization strategies mainly focused on harnessing the direct cancer cell killing property of M1-like macrophages repolarized from TAMs. However, the latent role of M1-like macrophages as professional antigen-presenting cells (APCs) also needs to be explored. Here, iron chelated melanin-like nanoparticles (Fe@PDA-PEG) were developed for M2-to-M1 TAMs repolarization and photothermal therapy (PTT) induced tumor-associated antigens (TAAs) releasing, which would exploit the potential of M1-like macrophages acquired as professional APCs for TAAs presentation. The results showed that M1 macrophages repolarized from TAMs by Fe@PDA-PEG could capture, process and present TAAs released by PTT through the major histocompatibility complex class II (MHC II) pathway, recruiting T-helper cells and effector T cells in tumor site, which leads to the controlled tumor growth and limited malignant metastasis.
肿瘤相关巨噬细胞(TAMs)在许多癌症中大量存在,主要表现出免疫抑制的 M2 样功能,促进肿瘤进展和恶性转移。目前 TAMs 再极化策略主要集中在利用从 TAMs 中重极化的 M1 样巨噬细胞的直接杀伤癌细胞的特性。然而,还需要探索 M1 样巨噬细胞作为专业抗原提呈细胞(APCs)的潜在作用。在这里,合成了一种铁螯合黑色素样纳米粒子(Fe@PDA-PEG),用于 M2 向 M1 TAMs 的再极化和光热治疗(PTT)诱导的肿瘤相关抗原(TAA)释放,从而利用 M1 样巨噬细胞作为专业 APCs 提呈 TAA 的潜力。结果表明,Fe@PDA-PEG 重极化的 M1 巨噬细胞可以通过 MHC II 途径捕获、加工和提呈 PTT 释放的 TAA,招募肿瘤部位的辅助性 T 细胞和效应 T 细胞,从而控制肿瘤生长,限制恶性转移。